Drug · DIN 02267640
AA-MEDROXY
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 16, 2024; first marketed August 4, 2005.
- Drug Identification Number (DIN)
- 02267640
- Company (DIN owner)
- AA Pharma Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Medroxyprogesterone G03DA02
- Class
- Human
- Record last updated
- August 20, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MEDROXYPROGESTERONE ACETATE | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 20, 2024: NOC 33474Abbreviated New Drug Submission (ANDS) · Administrative: Change in Product Ownership
- June 10, 2005: NOC 7084Supplement to an Abbreviated New Drug Submission (SANDS) · New strength
Other DINs named AA-MEDROXY
- DIN 02244726 · Marketed
- DIN 02244727 · Marketed
- DIN 02277298 · Marketed